Innovation has helped drug firms take on Big Pharma

India has also emerged a leader in novel drug delivery systems and custom synthesis of new molecules.
 
 
 
 

Troikaa Pharma gets patent approval for Dynapar AQ in CIS

Ahmedabad-based mid-sized pharmaceutical firm, Troikaa Pharmaceuticals Ltd has been granted the patent for ‘Dynapar AQ’, a diclofenac or painkiller injection, for the CIS block earlier this week.

  
 
 
Drugs chasing Dollars - All eyes on the US Generic Market

The emerging generic markets of the world are likely to outshine the US in the coming years but the fact remains that the US generic market is one of its kind - the perfect destination for the Indian generic manufacturers blessed with world class expertise but plagued with limited resources. What makes the US market special for Indian pharma companies? …a host of factors including the following
  
 
 
Intas Pharma inks supply deal with Astrazeneca
a
After Torrent Pharmaceuticals, another Ahmedabad based pharma firm Intas Pharmaceuticals Ltd has entered into a licensing and supply agreement with UK-based drug maker Astrazeneca. Intas will supply generic, high-end oncological products manufactured at its Matoda site near Ahmedabad to Astrazeneca. Intas declined to share the financial details of the deal.
  
 
 
 
 
Global pharma ups India generics focus

Rating agency ICRA said that it expects multinational pharmaceutical companies to increase their focus on branded generics business in India, as a part of their increased focus towards generic business globally.

  
 
   
 
 
CM gives nod to innovation park in MMR

Rating agency ICRA said that it expects multinational pharmaceutical companies to increase their focus on branded generics business in India, as a part of their increased focus towards generic business globally..
  
   
 
   
Readers can contribute Article, Reports, Case Studies, Success Stories,
Advertorials besides formal Advertisments.